======= G3BP1 ======= == Gene Information == * **Official Symbol**: G3BP1 * **Official Name**: G3BP stress granule assembly factor 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10146|10146]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13283|Q13283]] * **Interactions**: [[https://thebiogrid.org/search.php?search=G3BP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20G3BP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608431|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May be a regulated effector of stress granule assembly. Phosphorylation-dependent sequence-specific endoribonuclease in vitro. Cleaves exclusively between cytosine and adenine and cleaves MYC mRNA preferentially at the 3'-UTR. ATP- and magnesium- dependent helicase. Unwinds preferentially partial DNA and RNA duplexes having a 17 bp annealed portion and either a hanging 3' tail or hanging tails at both 5'- and 3'-ends. Unwinds DNA/DNA, RNA/DNA, and RNA/RNA substrates with comparable efficiency. Acts unidirectionally by moving in the 5' to 3' direction along the bound single-stranded DNA. {ECO:0000269|PubMed:11604510, ECO:0000269|PubMed:9889278}. |NTF2| |RRM 1| |positive regulation of stress granule assembly| |regulation of stress granule assembly| |type I interferon production| |stress granule assembly| |endonuclease activity| |DNA helicase activity| |RNA helicase activity| |cytoplasmic stress granule| |positive regulation of organelle assembly| |DNA duplex unwinding| |DNA geometric change| |perikaryon| |cytokine production| |ribonucleoprotein complex| |mRNA binding| |negative regulation of canonical Wnt signaling pathway| |defense response to virus| |negative regulation of Wnt signaling pathway| |regulation of organelle assembly| |ribonucleoprotein complex assembly| |ribonucleoprotein complex subunit organization| |Ras protein signal transduction| |positive regulation of protein complex assembly| |response to virus| |regulation of canonical Wnt signaling pathway| |DNA conformation change| |nucleic acid phosphodiester bond hydrolysis| |small GTPase mediated signal transduction| |regulation of Wnt signaling pathway| |focal adhesion| |regulation of protein complex assembly| |ribonucleoprotein complex biogenesis| |positive regulation of cellular component biogenesis| |positive regulation of organelle organization| |viral process| |organelle assembly| |innate immune response| |symbiotic process| |interspecies interaction between organisms| |cellular protein-containing complex assembly| |defense response to other organism| |regulation of cellular component biogenesis| |chromosome organization| |immune effector process| |positive regulation of cellular component organization| |negative regulation of signal transduction| |regulation of organelle organization| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |negative regulation of cell communication| |negative regulation of signaling| |RNA binding| |DNA binding| |ATP binding| |protein-containing complex assembly| |negative regulation of response to stimulus| |intracellular signal transduction| |protein-containing complex subunit organization| |immune response| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-2.62| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-2.44| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|-2.36| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-2.29| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|-1.94| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-1.85| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|1.7| |[[:results:exp209|Deguelin 0.15μM R05 exp209]]|1.77| |[[:results:exp16|DABN 2μM R00 exp16]]|1.8| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|1.8| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|1.83| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|1.84| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|1.85| |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|1.85| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|1.92| |[[:results:exp241|QNZ 0.01μM R05 exp241]]|1.92| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|1.95| |[[:results:exp123|GSK-LSD1 10μM R03 exp123]]|2.15| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|2.18| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|2.22| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|2.28| |[[:results:exp116|AICAR 240μM R03 exp116]]|2.33| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|2.45| |[[:results:exp212|Phenformin 20μM R05 exp212]]|2.62| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|2.89| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.93| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|3.15| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|3.18| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|4.03| ^Gene^Correlation^ |[[:human genes:e:elf1|ELF1]]|0.48| |[[:human genes:t:tnpo1|TNPO1]]|0.451| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2934 * **Expression level (log2 read counts)**: 9.08 {{:chemogenomics:nalm6 dist.png?nolink |}}